ClinicalTrials.gg
Not yet recruitingNCT07689032Updated Jul 7, 2026

Evaluation of Wear Resistance of CAD/CAM Hybrid Ceramic and Nano-Hybrid Composite Overlays in Endodontically Treated Molars and Their Effect on Natural Antagonist Teeth

An interventional study of SHOFU Hard blocks and BRILLIANT Crios in Wear, Occlusal, sponsored by Cairo University. Not yet recruiting. Open to participants aged 22 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-07-07.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
22 Years to 45 Years
Sex
All
01

Study summary

This randomized clinical trial aims to to evaluate and compare the 24-month surface wear of the restoration and the surface wear of the opposing natural tooth structure of CAD/CAM Hybrid Ceramic (SHOFU Hard blocks) versus Resin-based Composite (BRILLIANT Crios) overlays, utilizing a digital subtraction methodology (Intraoral Scanner and Geometrical Subtraction Software) in endodontically treated molar teeth.

Read the detailed description

The rationale for this 24-month RCT is driven by the need for high-level, evidence-based data to guide clinical material selection for compromised teeth. This trial is designed to directly compare two materials specifically engineered to be stress-absorbing in the oral environment. The primary intervention, the SHOFU Restorative System (Hard blocks), is a Hybrid Ceramic engineered to combine the durability of ceramics with the elasticity of polymers. Its reduced hardness and dentin-like modulus allow for rapid machining and are associated with reduced antagonist abrasion compared to conventional ceramics. The second material, serving as the comparator, is the Coltène Restorative System (BRILLIANT Crios), which is a reinforced nano-hybrid composite characterized by an elastic modulus comparable to dentin, designed for optimal shock absorption and confirmed to be gentle on antagonist teeth.

Focusing the study on endodontically treated molars addresses a highly prevalent clinical scenario where maximizing the longevity of the restoration and the remaining tooth structure is paramount. The use of a full-cusp-coverage overlay design represents the maximum conservation approach for these compromised teeth while ensuring that the selected restorative materials do not exert harmful effects on opposing dentition.

02

Conditions studied

  • Wear, Occlusal

Browse trials for

03

In context

Tooth Attrition

14 studies on the registry are indexed under Tooth Attrition; 5 are open to participants now.

This study's planned enrollment of 24 is close to the median of 26 across 11 interventional studies indexed under Tooth Attrition.

Browse Tooth Attrition studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 22 and 45 years.
  • Low to moderate caries risk.
  • Normal occlusion.
  • Absence of signs or symptoms of temporomandibular joint (TMJ) disorders.
  • Satisfactory oral hygiene.
  • Medically fit to receive routine restorative dental treatment.
  • Permanent molars.
  • Asymptomatic endodontically treated teeth.
  • Homogeneous root canal fillings extending 1-2 mm from the radiographic apex.
  • Compound cavities.
  • Favorable occlusion.
  • Presence of both an adjacent tooth and a sound opposing tooth in occlusion

Exclusion criteria

Exclusion Criteria:

  • * Presence of bruxism.

    • Poor patient cooperation.
    • Inability or unwillingness to attend follow-up appointments.
    • Anticipated travel during the study period.
    • Poor oral hygiene.
    • Chronic or advanced periodontitis.
    • Known allergies to any of the materials used in the study.
    • Patients who are pregnant or breastfeeding.
    • Teeth with \<1" mm" of residual wall thickness.
    • Deep subgingival cavity margins.
    • Severe periodontal problems.
    • Radiographic signs of apical pathology.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    SHOFU Hard blocks

    CAD/CAM Hybrid Ceramic, Overlay restored using the SHOFU cementation system.

    Procedure: SHOFU Hard blocks

  • Active comparator
    BRILLIANT Crios

    Resin-based Composite, Overlay restored using the Coltène cementation system.

    Procedure: BRILLIANT Crios

Interventions

  • ProcedureSHOFU Hard blocks

    CAD/CAM Hybrid Ceramic, Overlay restored using the SHOFU cementation system.

  • ProcedureBRILLIANT Crios

    Resin-based Composite, Overlay restored using the Coltène cementation system.

06

What researchers measure

Primary outcomes

  1. Annual wear rate

    Digital Scanner +Geometrical Subtraction Software

    Time frame: 24 months

Secondary outcomes

  1. Functional properties, Biological properties and Esthetic properties

    FDI Criteria

    Time frame: 24 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07689032
Lead sponsor
Cairo University
Responsible party
Sara Salem Sayed Ahmed (PhD Candidate, Cairo University) — Principal investigator
First posted
Jul 7, 2026
Start date
Jul 2026 (estimated)
Primary completion
Jul 2028 (estimated)
Completion
Jul 2028 (estimated)
Last update
Jul 7, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion